IMMUNO STOCK NEWSLETTER: 03/21/25: $INMB terrific.
Post# of 35919

In more unknown Immuno stock $ESLA @ $.90s: w/ recent $16 one year target BynumETF... PATIENTS UPDATE DUE..Clinical Trial run by most prominent immuno scientist at M. Sloan Kettering in NYC. Most highly regarded hospital in the USA.
https://finance.yahoo.com/news/estrella-immun...00432.html
Website:
https://www.estrellabio.com/

